Skip to main content
Journal ArticleOPEN ACCESS

Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach

  • Ibrahim M
  • Uzairu A
  • Uba S
  • et al.
Future Journal of Pharmaceutical Sciences (2021) 7(1)
DOI: 10.1186/s43094-021-00279-3
N/ACitations
Citations of this article
2Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Ibrahim, M. T., Uzairu, A., Uba, S., & Shallangwa, G. A. (2021). Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach. Future Journal of Pharmaceutical Sciences, 7(1). https://doi.org/10.1186/s43094-021-00279-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free